Welcome to our dedicated page for Natera SEC filings (Ticker: NTRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Natera, Inc. filings document the regulatory record for a Nasdaq-listed diagnostics company focused on cell-free DNA and precision medicine. Recent Form 8-K reports furnish results of operations and financial condition, press releases, investor presentations and exhibit information tied to quarterly and annual reporting.
The company’s proxy materials describe board composition, director elections, committee assignments, executive compensation, equity-award disclosures and stockholder voting matters. Its filings also identify the registered common stock class, Nasdaq Global Select Market listing, governance actions and other material-event disclosures relevant to Natera’s public-company reporting.
Morgan Stanley Smith Barney LLC Executive Financial Services filed a Form 144 notice relating to proposed and recent resale of Common shares of NTRA. The notice lists 3,070 Restricted Stock Units proposed for sale on 04/26/2026. It also records prior 10b5-1 plan sales by Michael Burkes Brophy of 5,671 shares on 02/03/2026 and 785 shares on 03/10/2026.
Natera, Inc. director Herm Rosenman reported receiving equity-based compensation in the form of restricted stock units (RSUs). The filing shows two acquisitions of common stock via RSU awards on April 24, 2026, recorded at no cash cost per share to him.
One RSU grant was issued in lieu of quarterly board retainer fees of $23,750 and was fully vested at issuance, effectively converting a cash fee into share-based pay. A separate RSU award vests 25% immediately, with the remainder vesting in three equal quarterly installments, adding time-based incentives to his compensation.
Marcus Gail Boxer reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Marcus Gail Boxer reported receiving two grants of Restricted Stock Units (RSUs) on April 24, 2026 as equity compensation. One award of 222 RSUs was issued in lieu of quarterly board retainer fees of $21,875 and was fully vested at issuance. A separate grant of 108 RSUs provides that 25% vests immediately, with the remainder vesting in three equal quarterly installments. The filing shows Boxer's direct holdings after these transactions as 6,183 and 5,961 shares of common stock in the respective lines.
Chapman Rowan E reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Rowan E. Chapman reported two grants of common stock in the form of Restricted Stock Units (RSUs). One grant covers 222 RSUs issued in lieu of quarterly board retainer fees of $23,125, and these RSUs were fully vested at issuance. A second grant covers 114 RSUs, with 25% vesting immediately and the remaining RSUs vesting in three equal quarterly installments thereafter. Each RSU represents a contingent right to receive one share of Natera common stock, and the filing characterizes both transactions as awards rather than open-market purchases.
BOTHA ROELOF reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Roelof Botha reported stock-based compensation and updated holdings. On April 24, 2026, he received two grants of Common Stock in the form of Restricted Stock Units (RSUs), with awards of 222 and 132 shares at a stated price of $0.00 per share.
Footnotes explain one RSU grant was issued in lieu of quarterly board retainer fees of $26,875 and was fully vested at issuance, while another vests 25% immediately and the balance in three equal quarterly installments. After these awards, Form 4 shows direct holdings of 2,894 and 2,672 Common Stock shares in the respective accounts, plus an additional 1,154,198 shares held indirectly through estate planning vehicles.
Rubin Eric H reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Eric H. Rubin received a grant of 5 shares of common stock in the form of Restricted Stock Units (RSUs). These RSUs were issued in lieu of $1,125 in quarterly retainer fees for his Board service and were fully vested at issuance. Each RSU represents the right to receive one share of Natera common stock, and Rubin now holds 5 shares directly following this award.
Williams Brinkley Ruth reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Ruth Williams Brinkley received a grant of 86 Restricted Stock Units (RSUs) of common stock on April 24, 2026. These RSUs were issued in lieu of $17,500 in quarterly board retainer fees and were fully vested at issuance.
Each RSU represents the right to receive one share of Natera common stock, bringing her direct holdings to 5,475 shares after the transaction. This is a compensation-related equity award rather than an open-market share purchase or sale.
Bertagnolli Monica reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Monica Bertagnolli received an equity grant rather than cash fees for board service. She was issued 83 fully vested Restricted Stock Units (RSUs) on common stock in lieu of quarterly retainer fees of $16,875. Each RSU equals one share of common stock, bringing her direct holdings to 5,374 shares after this grant.
Baynes Roy D. reported acquisition or exercise transactions in this Form 4 filing.
Natera, Inc. director Roy D. Baynes received a grant of 83 shares of common stock in the form of Restricted Stock Units. These RSUs were issued in lieu of quarterly board retainer fees of $16,875 and were fully vested at issuance. Following this award, Baynes directly holds 18,512 shares of Natera common stock. Each RSU represents a right to receive one share of common stock, so the grant functions as non-cash, stock-based compensation for his board service.